Status epilepticus associated with platinum chemotherapy in a patient with cervical cancer: a case report

por Holman, Laura L., Ren, Yulan, Westin, Shannon N.
Publicado 2015

Pushing the envelope: expanding fertility sparing treatment of endometrial cancer

por Stewart, Katherine Ikard, Yates, Melinda S., Westin, Shannon N.
Publicado 2020

Unusual indolent behavior of leiomyosarcoma of the vagina: Is observation a viable option?

por Khafagy, Ayatallah M., Prescott, Lauren S., Malpica, Anais, Westin, Shannon N.
Publicado 2017

Phase I study of the PARP inhibitor talazoparib with radiation therapy for locally recurrent gynecologic cancers

por Lakomy, David S., Urbauer, Diana L., Westin, Shannon N., Lin, Lilie L.
Publicado 2019

The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer

por Jalloul, Randa J., Nick, Alpa M., Munsell, Mark F., Westin, Shannon N., Ramirez, Pedro T., Frumovitz, Michael, Soliman, Pamela T.
Publicado 2018

Distinct T cell receptor repertoire diversity of clinically defined high-grade serous ovarian cancer treatment subgroups

por Lee, Sanghoon, Zhao, Li, Little, Latasha D., Westin, Shannon N., Jazarei, Amir A., Fleming, Nicole D., Zhang, Jianhua, Futreal, P. Andrew, Sood, Anil K.
Publicado 2021

Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein

por Subbiah, Vivek, Westin, Shannon N, Wang, Kai, Araujo, Dejka, Wang, Wei-Lien, Miller, Vincent A, Ross, Jeffrey S, Stephens, Phillip J, Palmer, Gary A, Ali, Siraj M
Publicado 2014

Race and nodal disease status are prognostic factors in patients with stage IVB cervical cancer

por Nishio, Shin, Matsuo, Koji, Yonemoto, Koji, Shimokawa, Mototsugu, Hosaka, Masayuki, Kodama, Michiko, Miyake, Takahito M., Ushijima, Kimio, Kamura, Toshiharu, Westin, Shannon N., Soliman, Pamela T., Coleman, Robert L.
Publicado 2018

Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis()

por Pothuri, Bhavana, Alvarez Secord, Angeles, Armstrong, Deborah K., Chan, John, Fader, Amanda N., Huh, Warner, Kesterson, Joshua, Liu, Joyce F., Moore, Kathleen, Westin, Shannon N., Naumann, R. Wendel
Publicado 2020

A Modified 2 Tier Chemotherapy Response Score (CRS) and Other Histopathologic Features for Predicting Outcomes of Patients with Advanced Extrauterine High-Grade Serous Carcinoma af...

por Zhong, Yanping, Liu, Jinsong, Li, Xiaoran, Westin, Shannon N., Malpica, Anais, Lawson, Barrett C., Lee, Sanghoon, Fellman, Bryan M., Coleman, Robert L., Sood, Anil K., Fleming, Nicole D.
Publicado 2021

Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers

por Morris, Van K, Jazaeri, Amir, Westin, Shannon N, Pettaway, Curtis, George, Solly, Huey, Ryan W, Grinsfelder, Michaela, Shafer, Aaron, Johnson, Benny, Vining, David, Guo, Ming, Fellman, Bryan, Frumovitz, Michael
Publicado 2023

Targeting CCR2(+) macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer

por Wu, Yutuan, Jennings, Nicholas B., Sun, Yunjie, Dasari, Santosh K., Bayraktar, Emine, Corvigno, Sara, Stur, Elaine, Glassman, Deanna, Mangala, Lingegowda S., Lankenau Ahumada, Adrian, Westin, Shannon N., Sood, Anil K., Hu, Wei
Publicado 2022

Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma

por Berg, Hege F., Ju, Zhenlin, Myrvold, Madeleine, Fasmer, Kristine E., Halle, Mari K., Hoivik, Erling A., Westin, Shannon N., Trovik, Jone, Haldorsen, Ingfrid S., Mills, Gordon B., Krakstad, Camilla, Werner, Henrica M. J.
Publicado 2020

Understanding the Role of Advanced Practice Providers in Oncology in the United States

por Bruinooge, Suanna S., Pickard, Todd A., Vogel, Wendy, Hanley, Amy, Schenkel, Caroline, Garrett-Mayer, Elizabeth, Tetzlaff, Eric, Rosenzweig, Margaret, Hylton, Heather, Westin, Shannon N., Smith, Noël, Lynch, Conor, Kosty, Michael P., Williams, Stephanie F.
Publicado 2018

FBXW7 Mutations in Patients with Advanced Cancers: Clinical and Molecular Characteristics and Outcomes with mTOR Inhibitors

por Jardim, Denis L., Wheler, Jennifer J., Hess, Kenneth, Tsimberidou, Apostolia M., Zinner, Ralph, Janku, Filip, Subbiah, Vivek, Naing, Aung, Piha-Paul, Sarina A., Westin, Shannon N., Roy-Chowdhuri, Sinchita, Meric-Bernstam, Funda, Hong, David S.
Publicado 2014

Fertility-sparing treatment in early endometrial cancer: current state and future strategies

por Obermair, Andreas, Baxter, Eva, Brennan, Donal J., McAlpine, Jessica N., Muellerer, Jennifer J., Amant, Frédéric, van Gent, Mignon D. J. M., Coleman, Robert L., Westin, Shannon N., Yates, Melinda S., Krakstad, Camilla, Janda, Monika
Publicado 2020

Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients

por Mauland, Karen Klepsland, Ju, Zhenlin, Tangen, Ingvild Løberg, Berg, Anna, Kalland, Karl-Henning, Øyan, Anne Margrete, Bjørge, Line, Westin, Shannon N., Krakstad, Camilla, Trovik, Jone, Mills, Gordon B., Hoivik, Erling A., Johanna Werner, Henrica Maria
Publicado 2017

MET nucleotide variations and amplification in advanced ovarian cancer: characteristics and outcomes with c-Met inhibitors

por Tang, Chad, Fontes Jardim, Denis L., Falchook, Gerald S., Hess, Kenneth, Fu, Siqing, Wheler, Jennifer J., Zinner, Ralph G., Naing, Aung, Tsimberidou, Apostolia M., De Melo Galgiato, Debora, Westin, Shannon N., Meric-Bernstam, Funda, Kurzrock, Razelle, Hong, David S.
Publicado 2013

Adaptive responses in a PARP inhibitor window of opportunity trial illustrate limited functional interlesional heterogeneity and potential combination therapy options

por Labrie, Marilyne, Kim, Tae-Beom, Ju, Zhenlin, Lee, Sanghoon, Zhao, Wei, Fang, Yong, Lu, Yiling, Chen, Ken, Ramirez, Pedro, Frumovitz, Michael, Meyer, Larissa, Fleming, Nicole D., Sood, Anil K., Coleman, Robert L., Mills, Gordon B., Westin, Shannon N.
Publicado 2019

Tumor core biopsies adequately represent immune microenvironment of high-grade serous carcinoma

por Lara, Olivia D., Krishnan, Santhoshi, Wang, Zhihui, Corvigno, Sara, Zhong, YanPing, Lyons, Yasmin, Dood, Robert, Hu, Wei, Qi, Lisha, Liu, Jinsong, Coleman, Robert L., Westin, Shannon N., Fleming, Nicole D., Cristini, Vittorio, Rao, Arvind, Burks, Jared, Sood, Anil K.
Publicado 2019